SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,555 | +32.2% | 3,212 | +44.2% | 0.04% | +7.9% |
| Q2 2023 | $66,974 | -34.0% | 2,228 | -20.4% | 0.04% | -32.1% |
| Q1 2023 | $101,444 | -10.7% | 2,800 | -12.1% | 0.06% | -12.5% |
| Q4 2022 | $113,645 | +24.9% | 3,186 | +19.3% | 0.06% | +14.3% |
| Q3 2022 | $91,000 | -99.9% | 2,671 | +0.3% | 0.06% | +19.1% |
| Q2 2022 | $77,014,000 | +219940.0% | 2,663 | +143.0% | 0.05% | +62.1% |
| Q1 2022 | $35,000 | -16.7% | 1,096 | -24.1% | 0.03% | +7.4% |
| Q4 2021 | $42,000 | +61.5% | 1,444 | +46.6% | 0.03% | +92.9% |
| Q3 2021 | $26,000 | -33.3% | 985 | -16.7% | 0.01% | -54.8% |
| Q2 2021 | $39,000 | – | 1,183 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |